Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: ...

A three-judge appeals panel rejected Apple’s request to pause an April 30 order banning the company from charging a fee on in-app iPhone transactions processed outside its once-exclusive payment syste ...

Annual Meeting held in Chicago, USA, from May 30 to June 3, the results of the Phase Ib/II clinical study of 9MW2821 in combination with Toripalimab for the treatment of patients with ...

A woman was caught with an MK2 grenade fleeing a police checkpoint in Loei. Claiming self-defence, the suspect is linked to drug activities.

Check Point Software Technologies announced the launch of its India-based data residency instance of Check Point Harmony SASE ...

Tarlatamab prolonged both overall and progression-free survival in the treatment of small cell lung cancer, backing it as a ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

A guideline-recommended 6-week regimen of corticosteroids for pneumonitis associated with immunotherapy significantly ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Updated data on IBI363 monotherapy in patients with advanced NSCLC were reported (ClinicalTrials.gov, NCT05460767). As of the ...